Sangamo Therapeutics, Inc.

OrganizationUnited States· Biotech

Minutes holds 1 development and 1 deal naming Sangamo Therapeutics, Inc., recorded from September 2026.

Deals in Minutes

Deals naming Sangamo Therapeutics, Inc.
Company	Deal	Amount	Counterparties	Date ↓	Status
PTC Therapeutics, Inc.Biotech	AcquisitionST-920	Not recorded	Bought from Sangamo Therapeutics, Inc.	21 Sep	Closed

PTC Therapeutics, Inc.Not recorded
AcquisitionST-920, from Sangamo Therapeutics, Inc.
Biotech · 21 Sep · Closed

Showing 1–1 of 1

Acquirers in Minutes

PTC Therapeutics, Inc.Acquisition · ClosedSep 21, 2026

Sangamo Therapeutics, Inc.

PTC Therapeutics buys ST-920 from Sangamo Therapeutics

Deal · AcquisitionPTC Therapeutics, Inc., Sangamo Therapeutics, Inc., +1Biotech21 SepPR Newswire

Elsewhere in Biotech

Past 3 months in Activity →

Iambic Therapeutics raises $150 million in IPO

Deal · IPOIambic TherapeuticsBiotech14 OctBioPharma Dive

BioNTech says its mRNA head and neck cancer therapy missed a trial objective

BioNTechBiotech13 OctBioPharma Dive